logo

For the Inventor, By the Inventor

Brookline, MA, United States of America

Donald J Hnatowich

This inventor holds 6 USPTO granted patents. Top assignees: University of Massachusetts, Boston University, Immunomedics, Inc.. Active years: 1984-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Donald J Hnatowich. Retrieved from https://idiyas.com/inventor/donald-j-hnatowich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 2.1

ph-index = 6

Forward Citations = 236(Granted Patents)


Location History:

  • Worcester, MA (US) (1984 - 1987)
  • Brookline, MA (US) (1996 - 2005)

Company Filing History:

goldMedal4 out of 1,633 
 
University of Massachusetts
 patents
silverMedal2 out of 833 
 
Boston University
 patents
bronzeMedal1 out of 410 
 
Immunomedics, Inc.
 patents
where one patent can have more than one assignee

Years Active: 1984-2005

Loading Chart...
6 patents (USPTO):Explore Patents
1. 6899864 - Morpholino imaging and therapy (2005-05-31),
2. 5980861 - Chelator compositions and methods of synthesis thereof (1999-11-09),
3. 5965133 - Self-assembling multimeric nucleic acid constructs (1999-10-12),
4. 5561043 - Self-assembling multimeric nucleic acid constructs (1996-10-01),
5. 4668503 - Process for labeling amines with .sup.99m Tc (1987-05-26),
6. 4479930 - Amines coupled wth dicyclic dianhydrides capable of being radiolabeled (1984-10-30),

Title: The Innovations of Donald J Hnatowich

Introduction

Donald J Hnatowich is a notable inventor based in Brookline, MA, with a significant contribution to the field of medical diagnostics and therapeutics. He holds a total of six patents, showcasing his innovative approach to addressing complex health issues through advanced technologies.

Latest Patents

Among his latest patents is the invention titled "Morpholino imaging and therapy." This invention provides a kit and method for targeting a diagnostic or therapeutic agent to a specific site in a mammal suffering from a pathological condition. The kit includes a first conjugate that combines a targeting moiety with a Morpholino oligomer, which selectively binds to a primary, target-specific binding site. Additionally, it may contain a clearing agent and a second conjugate that includes a complementary Morpholino oligomer along with a diagnostic or therapeutic agent. Another significant patent is related to "Chelator compositions and methods of synthesis thereof," which discloses compositions of radiolabeled nucleic acids and methods for their synthesis and use.

Career Highlights

Donald has had a distinguished career, working at prominent institutions such as the University of Massachusetts and Boston University. His work has significantly impacted the field of molecular medicine, particularly in the development of targeted therapies.

Collaborations

Throughout his career, Donald has collaborated with esteemed colleagues, including Mary Rusckowski and Charles Cantor, further enhancing the scope and impact of his research.

Conclusion

Donald J Hnatowich's contributions to medical innovation through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in diagnostic and therapeutic techniques.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…